Dallas-based Tenet CEO Saum Sutaria, MD, was paid 711 times more than the health system’s median employee in 2025, according to a proxy statement filed April 16 with the Securities and Exchange Commission.
Dr. Sutaria’s total compensation was $43,108,969 in 2025. The annual total compensation of Tenet’s median-compensated employee was $60,657. The ratio of these amounts is 711 to 1.
Tenet identified the median compensated employee using total gross wages earned during calendar year 2025 for all employees employed for the full year. Pay was annualized for permanent employees not employed for a full year in 2025. The health system had approximately 98,000 employees as of Dec. 31. The system excluded about 4,129 employees based in the Philippines, as permitted by SEC rules.
The SEC requires public companies to disclose how CEO pay stacks up with the median employee’s overall compensation each year.
In 2024, Tenet’s CEO-to-worker pay ratio was 406 to 1. Dr. Sutaria’s total compensation was $24,661,553 and Tenet’s median-compensated employee earned $60,698.
In 2025, Dr. Sutaria received $31.7 million in stock awards, compared to $15.1 million in 2024. He also received $9 million in non-equity incentive plan compensation in 2025, up from $6.8 million in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
